Cancer Chemotherapy Flashcards
Aldesleukin (IL-2)
Inc. lymphocyte differentiation and inc NKs: renal cell cancer and metastatic melanoma
Interleukin-11
Platelet formation
Filgrastim (G-CSF)
Granulocyte formation (marrow recovery)
Sargramostim (GM-CSF)
Granulocyte and macrophage recovery
MOPP
Mechlorethamine- alkylating agent; Oncovin= inhibitor of microtubules; Procarbazine- alkylating agent; Prednisone- apoptosis inducer
MOPP Toxicity
Bone marrow suppression, allergic reaction, infertility, high risk of acute leukemia
ABVD
Adriamycin-topoisomerase inhibitor; Bleomicin-free radical producer; Vinblastine- microtubule inhibitor; Dacarbazine-alkylating agent
ABVD Toxicity
Hair loss, N/V, myelosuppression, neuropathy
Tumor Lysis Syndrome
HYPERKALEMIA (cardiac conduction), HYPERPHOSPHOTEMIA (renal precipitates), HYPOCALCEMIA (renal precipitate, tetany, myopathy), Hyperuricemia/uricosuria (acute uric acid nephropathy)
antimetabolites (CCS)
Folate antagonists; pyrimidine analogs; Purine analogs: S phase specific
Folate antagonists
Methotrexate; Pemetrexed; 5-Fluorouracil; Capecitabine
Methotrexate
ALL; breast cancer; AE: reversible suppression of bone marrow (treated with Leucovorin Rescue); MOA: Reduced folate carrier brings it into the cell uses FPGS enzyme to remain in cells
Pemetrexed
Lung Cancer; AE: reversible suppression of bone marrow (treated with Leucovorin Rescue MOA: Same as methotrexate but does not use FPGS enzyme
5-flourouracil
Carcinomas of GI; breast cancer; AE: coronary atherosclerosis, alopecia, thrombophlebitis MOA: blocks thymidylate synthase (converts dUMP to dTMP)
Capecitabine
Metastatic colorectal cancer AE: coronary atherosclerosis, alopecia, thrombophlebitis MOA: blocks thymidylate synthase (converts dUMP to dTMP)